Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Dermatology

Merck & Co. Inc.’s immune-stimulating melanoma drug, Keytruda (pembrolizumab) has received FDA approval, a Reuters article says. The drug, which is designed to stimulate the immune system to fight off cancer by blocking PD-1 proteins, is the...
According to an article published by Reuters, Eli Lilly and Company has announced an improved experimental drug used to treat psoriasis. The drug, ixekizumab, proved to have significantly greater levels of skin clearance than current generic therapies or...
According to an article published by CNN, the United States surgeon general issued a skin cancer warning on Tuesday, with the American Cancer Society saying it is a major public health problem with more cases diagnosed annually than breast, prostate,...